Beruflich Dokumente
Kultur Dokumente
GROUP 13
FACULTY OF MEDICINE TARUMANAGARA
UNIVERSITY
2013
Acute Coronary
Syndrome
Definition
Any condition brought on by sudden, reduced blood
flow to the heart.
ST-segment elevation myocardial infarction (STEMI)
nonST-segment elevation myocardial infarction
(NSTEMI) or in unstable angina
Epidemiology
ACS is almost always associated with rupture of an
atherosclerotic plaque and partial or complete
thrombosis of the infarct-related artery.
It's important to recognize the patient with unstable
angina, because 5-17% suffer an MI within a week
after admission & 3-15% die within a year.
Etiology
Acute coronary syndrome (ACS) is caused
primarily by atherosclerosis.
Most cases of ACS occur from disruption of a
previously nonsevere lesion (an atherosclerotic
lesion that was previously hemodynamically
insignificant yet vulnerable to rupture).
Risk Factors
Older age (older than 45 for men and older than 55 for
women)
High blood pressure
High blood cholesterol
Cigarette smoking
Lack of physical activity
Type 2 diabetes
Family history of chest pain, heart disease or stroke
Pathophysiology
Normal
Fatty
streak
Fibrous
plaque
Atherosclerotic
plaque
Plaque
rupture/
fissure &
thrombosis
Unstable
angina
Ischemic
stroke/TIA
Clinically silent
Stable angina
Intermittent claudication
Critical leg
ischemia
Cardiovascular
death
Increasing age
Assessment
Onset
Provocation
Allergies
Quality
Medications
Radiation
Severity
Time
Criteria Diagnose
History
ECG changes
Serial changes in cardiac enzymes (detectors of
myocardial damage)
History
Palpitations
Pain, feels like pressure, squeezing, or a burning
sensation across the precordium & may radiate to the
neck, shoulder, jaw, back, upper abdomen or arm
Exertional dyspnea that resolves with pain or rest
Diaphoresis
Nausea
ECG
Changes that may be seen during anginal episodes
include the following:
Transient ST-segment elevations
Dynamic T-wave changes - Inversions, normalizations,
or hyperacute changes
ST depressions - May be junctional, downsloping, or
horizontal
Differential Diagnosis
Aortic Stenosis
Asthma
Cardiomyopathy
Myocardial Infarction
Myocarditis
Pericarditis and Cardiac Tamponade
Complications
Pulmonary edema
Myocardial Infarct
MYOCARDIAL
INFARCTION
Myocardial necrosis due to blood flow
to the heart muscle impaired
Non-ST elevation Myocardial Infarction
ST elevation Myocardial Infarction
NON-ST ELEVATION
MYOCARDIAL
INFARCTION
a subtotally blockage in the coronary
artery in the first few hours and
disappear over time and there is
evidence myocardial infarction
(elevated cardiac biomarker)
Pathophysiology
oxygen supply or myocardial
oxygen demand superimposed on a
lesion (coronary arterial obstruction
atherothrombotic coronary plaque)
Myocardial
Infarction
RISK FACTOR:
1.Smoking
2.Hypertension
3.hypercholesterolemia
Myocardial Infarction
thrombus coronary artery
Ruptur plaque
Tromboxan A2
Thrombosit activation
Agonis (kolagen, ADP, epinefrin dan serotonin)
Risk Factors
age > 65 years
three or more risk factors for CAD (carotid
artery disease),
documented CAD at catheterization,
development of UA/NSTEMI while on
aspirin,
more than two episodes of angina within
the preceding 24 h
ST deviation 0.5 mm, and an elevated
cardiac marker
Clinical manifestation
chest pain
located in the substernal region or
sometimes in the epigastrium, that
radiates to the neck, left shoulder,
and/or the left arm
dyspnea and epigastric discomfort
Clinical manifestation
Diaphoresis
cool skin
sinus tachycardia
a third and/or fourth heart sound
basilar rales (crackles) inflamation,
fluid or infection.
Hypotension resembling the
findings of large STEMI.
Diagnosis
clinical history
ECG
Cardiac markers (recognize or
exclude MI )
Stress testing (coronary imaging is
an emerging option).
Electrocardiogram
ST-segment depression, transient STsegment elevation, and/or T-wave
inversion occur in 30 to 50% of
patients
Cardiac Biomarkers
elevated biomarkers of necrosis,
such as CK-MB > 3 ng/ml and
troponin >0.4 ng/ml
High risk mortality if troponin
incrase.
Prognosis
NSTEMI exhibit a wide spectrum of
early (30 days) risk of death, ranging
from 1 to 10%, and of new or
recurrent infarction of 35% or
recurrent ACS (5-15%).
ST ELEVATION
MYOCARDIAL
INFARCTION
a complete blockage in the coronary
artery
ETIOLOGI
coronary artery occlusion caused by
coronary emboli
congenital abnormalities
coronary spasm
wide variety of systemicparticularly
inflammatorydiseases
Pathophysiology
coronary artery thrombus (rapidly) at a site of
vascular injury surface atherosclerotic plaque
disrupted (rich lipid core and a thin fibrous cap )
thrombus forms coronary artery occlusion
coronary blood flow.
thrombotic occlusion (atherosclerosis) or
stenosis (slowly) coronary artery coronary
blood flow.
Vascular injury cigarette smoking,
hypertension, and lipid accumulation
Ruptur
plaque
Ruptur initial
monolayer platelet
form
collagen, ADP,
epinephrine,
serotonin
resistance to
fibrinolysis
tromboksan A2
(vasoconstrictor)
platelet activator
platelet cross-linking
and aggregation and
fibrin strands
change in the
glycoprotein
IIb/IIIa receptor
coagulation
cascade
activated
Factors VII and X
are activated
prothrombin to
thrombin
And
fibrinogen to fibrin
RISK FACTORS
Unstable angina
Hypercoagulability
collagen vascular disease
cocaine abuse
intracardiac thrombi or masses that
can produce coronary emboli.
diabetes mellitus and age
Clinical manifestation
Precipitating factor
present before STEMI (vigorous physical
exercise, emotional stress, or a medical or
surgical illness).
Physical examination
Chest Pain (persisting for >30 min)
anterior infarction sympathetic
nervous system hyperactivity
(tachycardia and/or hypertension),
abnormal systolic pulsation
inferior infarction show evidence of
parasympathetic hyperactivity
(bradycardia and/or hypotension).
LABORATORY
1. acute (first few hours7 days)
2. healing (728 days)
3. healed (> 29 days)
ECG, serum cardiac biomarkers,
cardiac imaging, nonspecific indices
of tissue necrosis and inflammation.
Electrocardiogram
initial stage, total occlusion of an
epicardial coronary artery ST-segment
elevation
Depresion Q waves
ST-segment elevation will not develop Q
waves the obstructing thrombus is not
totally occlusive
transmural MI Q waves or loss of R
waves and nontransmural MI only
transient ST-segment and T-wave changes
Cardiac Biomarkers
Cardiac-specific troponin T (cTnT)
and cardiac-specific troponin I (cTnI)
troponin >0.4 ng/ml elevated
for 710 days after STEMI.
CKMB > 3 ng/ml
Cardiac Imaging
detected accurately with highresolution cardiac MRI
Initial Management
MANAGEMENT STRATEGIES
Control of Discomfort
Nitroglycerin three doses of 0.4 mg
at about 5-min intervals
myocardial oxygen demand (by
lowering preload) and myocardial
oxygen supply (vasoditasion).
KI : low systolic arterial pressure (<90
mmHg)
Fibrinolysis
Hospital Phase
Management
Coronary Care Unit
The cardiac ritm of each patient and
hemodynamic monitor in selected
patients
Activity
Factor that increase the work of the
heart increase the size of the infarct.
Bed rest for the first 12 h.
Diet
30% total calories
fat and cholesterol 300 mg/d
high potassium, magnesium, and fiber,
low in sodium
Bowel management
Bed rest Conspations dioctyl
sodium sulfosuccinate (200 mg/d)
Sedation
Diazepam (5 mg),
oxazepam (1530 mg),
lorazepam (0.52 mg),
given 34 times daily
DD
acute pericarditis (Radiation of
discomfort to the trapezius )
pulmonary embolism
acute aortic dissection
Costochondritis
gastrointestinal disorders
Complication
Ventricular Dysfunction
Hemodynamic Assessment
Hypovolemia
UNSTABLE
ANGINA
UNSTABLE ANGINA
it occurs at rest (or with minimal exertion),
usually lasting >10 minutes.
it is severe and of new onset (i.e., within the
prior 46 weeks).
it occurs with a crescendo pattern (i.e.,
distinctly more severe, prolonged, or frequent
than previously).
Etiology
Atherosclerotic narrowing of coronary
vessels
Vasospasm, although this is usually at
rest and considered unstable if new onset
Microvascular angina or abnormal
relaxation of vessels with diffuse vascular
disease
Plaque disruption
Thrombosis
Arteritis:
Lupus
Takayasu disease
Kawasaki disease
Rheumatoid arthritis
Anemia:
Hemoglobin <8 g/dL
Hyperbarism or elevations in carboxyhemoglobin
Coronary artery gas embolus
Thyroid storm
Structural abnormalities of coronary arteries:
Radiation fibrosis
Aneurysms
Ectasia
Cocaine- or amphetamine-induced
vasospasm
Cardiac risk factors include:
Hypercholesterolemia
Diabetes mellitus
Hypertension
Smoking
Family history in a first-degree relative less
than age 55
Men: age >55 years
Postmenopausal women
Diagnosis
Signs and Symptoms
Unstable angina is defined by either:
New-onset symptoms
Symptoms that occur at rest
A change in the patient's usual pattern
of angina
Chest pain:
Most common
presentation of
myocardial
infarction
Substernal pressure
Heaviness
Squeezing
Burning sensation
Tightness
Occasional anginal
equivalents:
Abdominal pain
Syncope
Diaphoresis
Nausea or vomiting
Weakness
Physical Exam
Physical exam is usually unrevealing.
Occasional physical findings include:
S3 or S4 due to left ventricular systolic
or diastolic symptoms
Papillary muscle dysfunction resulting in
mitral regurgitation
Diminished peripheral pulses
Tests
ECG:
Will be normal approximately 50% of the time
ST segment changes or T-wave inversions most
often will be unchanged from previous tracings.
Must be compared to prior tracings if available
New ST segment changes or T-wave inversions
are suspicious for unstable angina.
Serial ECG tracings that remain unchanged
may assist in differentiating stable from
unstable angina.
1-mm depression of the ST segment below the
baseline, 80 msec from the J point, is
characteristic of angina
Lab
Imaging
Chest radiograph:
Usually normal
May show cardiomegaly
Congestive heart failure is suggestive of
unstable angina.
May identify other etiologies of chest pain
such as pneumonia
Differential Diagnosis
Acute MI
Anxiety
Aortic dissection
Biliary colic
Costochondritis
Esophageal reflux
Esophageal spasm
Herpes zoster
Panic disorder
Peptic ulcer disease
Pneumonia
Psychogenic
Pulmonary embolus
Hiatal hernia
Mitral valve prolapse
MI
Treatment
Pre Hospital
IV access
Aspirin
Oxygen
Cardiac monitoring
Sublingual nitroglycerin for symptom
relief
Initial Stabilization
IV access
Oxygen
Cardiac monitoring
Oxygen saturation
Continuous BP monitoring and pulse
oximetry
Drugs
Aspirin
Enoxaparin
Glycoprotein IIb/IIIa
inhibitors:
Eptifibatide
(Integrilin):
Tirofiban
(Aggrastat):
Abciximab (ReoPro):
Heparin
Metoprolol
Morphine
Nitroglycerin
Nitroglycerin
Nitropaste
CARDIAC
ARREST
8686
Epidemiology
50% of all cardiac deaths are sudden & unexpected, at
least two-thirds of which are first cardiac events or
occur among population subsets with previously known
heart disease.
Diagnostic Tests
Laboratory tests :
Electrolytes
Blood urea nitrogen/creatinine
Creatinine kinase with isoenzymes, cardiac troponin
Arterial blood gas
CBC
Therapeutic drug levels
Toxicological testing
ECG :
Establish or rule out acute coronary syndrome
Pericardial effusion
Wall motion abnormality
Valvular dysfunction
CXR :
Endotracheal tube position
Cardiac silhouette
Pneumothorax
Differential Diagnose
Sudden loss of consciousness with a palpable pulse:
Syncope
Seizure
Acute stroke
Hypoglycemia
Acute airway obstruction
Head trauma & toxins
Management
The initial response : basic life support & public
access defibrillation (if available)
Advanced life support
Post-resuscitation care
Long-term management
Management (Pre-Hospital)
Prompt
initiation
of
standard
CPR
active
Post-resuscitation care:
- Identify cause of arrest
- 12-lead ECG
- Monitor vital signs
If
return
of
spontaneous
circulation,
consider
Prolonged arrest
Initial Stabilization
Obtain IV access
Cardiac monitor
ED Treatment
Pulseless VT or VF
Immediate defibrillation with up to three countershocks:
200 J
200 - 300 J
360 J
If defibrillation is unsuccessful:
Epinephrine
Vasopressin
Asystole
Epinephrine
Atropine
PEA
Epinephrine
Atropine
- Pneumothorax
- Cardiac tamponade
- Hypoxia
- Pulmonary embolus
- Hypovolemia (hemorrhage)
Medication (Drugs)
Amiodarone
Magnesium
Atropine
Procainamide
Epinephrine
Sodium bicarbonate
Lidocaine
Vasopressin
Post Resuscitation
Treat the underlying cause of the arrest
Ventilatory support
Continue antidysrhythmic therapy
Correct electrolyte abnormalities
ECG Emergency
CARDIORESPIRATOR
Y RESUSCITATION
Definition
CPR is an organized, sequential response
to cardiac arrest, including
Recognition of absent breathing and circulation
Basic life support with chest compression and
rescue breathing
Advanced cardiac life support (ACLS) with
definitive airway and rhythm control
Postresuscitative care